C.A. Lawton

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31

Miljenko V. Pilepich, Kathryn Winter, C.A. Lawton et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 920 citations

Medicine, Oncology, Urology +16

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

Miljenko V. Pilepich, Kathryn Winter, Madhu J. John et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 774 citations

Medicine, Oncology, Radiation Oncology +17

Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02

Gerald E. Hanks, Thomas F. Pajak, Arthur T. Porter et al. · Journal of Clinical Oncology · 2003 · 694 citations

Medicine, Oncology, Radiation Oncology +17

Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer

Eric M. Horwitz, Kyounghwa Bae, Gerald E. Hanks et al. · Journal of Clinical Oncology · 2008 · 691 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology group

Miljenko V. Pilepich, William T. Sause, William U. Shipley et al. · Urology · 1995 · 489 citations

Medicine, Oncology, Radiation Oncology +17